Federal cannabis reform is supposed to open the same door for everyone. The current market says otherwise.

The largest operators do not share one political agenda, and some of the barriers they complain about are also widening their moats. As capital markets, international medical standards, and state regulation collide, the operators built for uncertainty may be the ones hardest to dislodge.

This week we sit down with Jay Rosenthal

• Limbo as a moat
• EU GMP advantage
• Regulation's hidden winners

• 00:00 Federal limbo becomes the business model
• 02:17 The reform everyone agrees on
• 03:28 Capital markets and the bigger pond
• 05:35 Six hundred brands and no patience
• 06:55 Why Rochester can move New York
• 09:48 Strong operators become obvious
• 13:40 The cost of crossing state lines
• 16:28 Aurora Curaleaf and scarce EU GMP assets
• 20:26 The Canadian future that did not arrive
• 22:00 What mature industry compliance could bring
• 24:35 Cultivated's nonsecret sauce
• 31:41 Cannabis stigma still follows the operator
• 32:28 Why Cultivated launched membership
• 40:23 Quality media has a real cost
• 41:18 California and New York regulators share a market
• 44:02 Policy goals that fight each other
• 49:06 Competition cooperation and price compression
• 52:25 Where to find Jay and Cultivated

• Jay Rosenthal - Co-Founder and Managing Director of Cultivated Media
• Cultivated Media
• Cultivated events
• Sign up for the Cultivated Daily newsletter

• The Dime Podcast — website
• Bryan Fields on X
• The Dime on X
• The Dime on YouTube
• The Dime on Instagram
• Newton Insights — insights for extraction teams

Follow The Dime for more conversations on cannabis business, operations, and international markets.

Share this episode with an operator rethinking their edibles.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.